top of page

Vetenskapliga studier på mRNA

COVID-19 Vaccine-Induced Expansion of Pituitary Adenoma

Cancer

Breast Cancer Screening and Axillary Adenopathy in the Era of COVID-19 Vaccination

Cancer

Axillary lymphadenopathy in a high-risk breast screening patient following the COVID-19 vaccine a diagnostic conundrum

Cancer

Association Between Simian Virus 40 and Human Tumors

Cancer

Thrombosis With Thrombocytopenia After the Messenger RNA-1273 Vaccine

Trombose

Thrombosis Development After mRNA COVID-19

Trombose

The spectrum of non-fatal immune-related adverse events following COVID-19 vaccination

Trombose

The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia

Trombose

Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19

Trombose

Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination

Trombose

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia

Trombose

Potential Triggers for Thrombocytopenia and or Hemorrhage by the BNT162b2 Vaccine, Pfizer-BioNTech

Trombose

Post-mortem findings in vaccine-induced thrombotic thombocytopenia

Trombose

Portal vein thrombosis occurring after the first dose of mRNA SARS-CoV-2 vaccine in a patient with antiphospholipid syndrome

Trombose

Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration

Trombose

mRNA COVID-19 Vaccine–Related Anaphylactoid Reaction and Coronary Thrombosis

Trombose

Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia

Trombose

Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination, a systematic review and meta-analysis

Trombose

Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccine

Trombose

Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine

Trombose

bottom of page